Cetera Advisors’s Aurinia Pharmaceuticals AUPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $301K | Buy |
60,139
+9,547
| +19% | +$47.8K | ﹤0.01% | 1937 |
|
|
2023
Q4 | $455K | Buy |
50,592
+2,400
| +5% | +$21.6K | 0.01% | 1187 |
|
|
2023
Q3 | $374K | Buy |
48,192
+2,828
| +6% | +$22K | 0.01% | 1212 |
|
|
2023
Q2 | $439K | Buy |
45,364
+1,065
| +2% | +$10.3K | 0.01% | 1129 |
|
|
2023
Q1 | $486K | Buy |
44,299
+8,999
| +25% | +$98.6K | 0.01% | 1036 |
|
|
2022
Q4 | $152K | Hold |
35,300
| – | – | ﹤0.01% | 1474 |
|
|
2022
Q3 | $265K | Buy |
35,300
+300
| +0.9% | +$2.25K | 0.01% | 1025 |
|
|
2022
Q2 | $352K | Buy |
35,000
+3,251
| +10% | +$32.7K | 0.01% | 983 |
|
|
2022
Q1 | $393K | Buy |
31,749
+4,550
| +17% | +$56.3K | 0.01% | 983 |
|
|
2021
Q4 | $622K | Sell |
27,199
-1,069
| -4% | -$24.4K | 0.01% | 797 |
|
|
2021
Q3 | $626K | Buy |
28,268
+16,163
| +134% | +$358K | 0.01% | 792 |
|
|
2021
Q2 | $157K | Buy |
+12,105
| New | +$157K | ﹤0.01% | 1268 |
|